Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, October 14, 2021
Avid Bioservices, a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, ...
read more
Thursday, February 25, 2021
Avid Bioservices announced the initiation of Phase 2 of the company’s two-phase effort to expand the overall manufacturing capacity within its Myford facility.
read more
Avid Bioservices, Inc. announced that the company is further expanding its process development capacity for its mammalian cell business. As part of these efforts, Avid is expanding its state-of-the-art laboratories which could support an additional $...
read more
Avid Bioservices Inc., a dedicated biologics contract development and manufacturing organization (CDMO), announced that it will serve as the commercial manufacturer for the humanized monoclonal antibody portion of ZYNLONTA™ (loncastuximab tesirine-...
read more
Avid Bioservices and Argonaut announced an to provide clients an integrated manufacturing solution including process development, drug substance manufacturing, and drug product manufacturing.
read more
Thursday, August 27, 2020
Mapp has contracted Avid to provide process transfer, scale-up and clinical manufacturing services to support one of its development programs for a novel antiviral drug candidate.
read more
Avid announced that Acumen has selected Avid to provide process development and clinical manufacturing services in support of ACU193.
read more
Iovance Biotherapeutics has selected Avid to provide process development, pilot-batch manufacturing and CGMP manufacturing services to support development of IOV-3001.
read more
Wednesday, November 02, 2022
Avirmax CMC Inc. has completed its brand-new facility in Hayward, CA (San Francisco Bay Area). The facility has received cGMP license approval by the California Department of Public Health (CDPH)-Food & Drug Branch, for the production of rAAV drug ...
read more
Tuesday, December 19, 2017
Avista has completed extensive facility upgrades at its Longmont, Colorado site.
read more
Avista Pharma Solutions has completed the acquisition of Solid Form Solutions located in Edinburgh, Scotland.
read more
Monday, November 13, 2017
Avista Pharma Solutions has completed facility upgrades that effectively double the company’s API manufacturing capacity at its Longmont, Colorado site.
read more
Avrio Biopharmaceuticals, LLC, a leading global cGMP contract aseptic manufacturing organization, announced the appointment of Laura Jones, Ph.D., J.D., M.S., M.B.A., as Vice President of Quality and Regulatory Affairs. Dr. Jones will be responsible ...
read more
Axovant Gene Therapies has signed a strategic partnership with Yposkesi a CDMO for preferred access and reserved capacity for cGMP grade viral vector production.
read more
Azenta entered an agreement to acquire B Medical Systems S.á r.l and its subsidiaries ("B Medical"). B Medical is a provider of temperature-controlled storage and transportation solutions globally.
read more